Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Sleep / Sleep Disorders / Insomnia News

Takeda Withdraws Its Marketing Authorisation Application For Ramelteon, Europe

Main Category: Sleep / Sleep Disorders / Insomnia
Also Included In: Regulatory Affairs / Drug Approvals
Article Date: 25 Sep 2008 - 10:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:4 stars

4 (1 votes)

Article Opinions: 0 posts

The European Medicines Agency (EMEA) has been formally notified by Takeda Global Research & Development Centre (Europe) Ltd of its decision to withdraw its application for a centralised marketing authorization for the medicine Ramelteon (ramelteon) 4 and 8 mg tablets. Ramelteon was expected to be used for the treatment of primary insomnia in patients aged 18 years or over.

The application for marketing authorisation for Ramelteon was submitted to the EMEA on 21 March 2007. On 30 May 2008, the Committee for Medicinal Products for Human Use (CHMP) adopted a negative opinion, recommending the refusal of the marketing authorisation for the medicine. Following this, the company requested a re-examination of the opinion, which was under review by the CHMP at the time of the withdrawal.

In its official letter, the company stated that the withdrawal of the application was based on its current plan to consider seeking scientific advice with a view to extending the clinical programme, which would address the CHMP's questions regarding the medicine's benefit-risk profile.

More information about Ramelteon and the state of the re-examination procedure at the time of withdrawal will be made available in a question-and-answer document. This document, together with the withdrawal letter from the company, will be published on the EMEA website in due course.

Notes

1. Withdrawal of an application does not prejudice the possibility of a company making a new application at a later stage.

2. More information about the CHMP's negative opinion on Ramelteon is available in a question and answer document: http://www.emea.europa.eu/pdfs/human/opinion/Ramelteon_26821608en.pdf

3. This press release, together with other information on the work of the EMEA, can be found on the EMEA website: http://www.emea.europa.eu

European Medicines Agency




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Please fill in our survey

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Long-Held Theory About Biological Clocks Overturned By U-M Discovery
09 Oct 2009
University of Michigan mathematicians and their British colleagues say they have identified the signal that the brain sends to the rest of the body to control biological rhythms, a finding that overturns a long-held theory about our internal clock...


Seasonal Depression image Seasonal Depression

Every winter, when the days get shorter, people with seasonal affective disorder, also known as SAD, experience depression. Learn how light can help chase away the winter blues...

Bedtime Basics image Bedtime Basics

Bedtime can be a scary time for kids who share their room with a monster. See how parents can help kids make the transition to sleep with a healthy dose of creativity and support...

View more videos...